Arvinas (ARVN) Cash from Investing Activities (2017 - 2026)

Arvinas' (ARVN) quarterly Cash from Investing Activities came in at $13.7 million in Q1 2026, down 80.29% year-on-year from $69.5 million in Q1 2025, and down 90.6% quarter-over-quarter from $145.8 million in Q4 2025.

Arvinas (ARVN) Cash from Investing Activities (2017 - 2026) Analysis & Trends

Arvinas' Cash from Investing Activities history runs 10 years deep, the most recent figure standing at $13.7 million for Q1 2026.

  • On a quarterly basis, Cash from Investing Activities fell 80.29% year-over-year to $13.7 million in Q1 2026; TTM through Mar 2026 was $351.8 million, a 51.64% increase from a year earlier, with the FY2025 full-year figure at $407.6 million, up 1074.64% from the prior year.
  • Cash from Investing Activities fell to $13.7 million in Q1 2026 per ARVN's latest filing, from $145.8 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $145.8 million in Q4 2025 and bottomed at -$127.8 million in Q1 2024.
  • The 5-year median for Cash from Investing Activities is $63.5 million (2025), against an average of $53.1 million.
  • Biggest YoY gain for Cash from Investing Activities was 1511.63% in 2023; the steepest drop was 376.8% in 2023.
  • Year by year, Cash from Investing Activities stood at $19.4 million in 2022, then plunged by 376.8% to -$53.7 million in 2023, then surged by 284.17% to $98.9 million in 2024, then jumped by 47.42% to $145.8 million in 2025, then sank by 90.6% to $13.7 million in 2026.
  • Per Business Quant, the three latest ARVN Cash from Investing Activities figures stand at $13.7 million (Q1 2026), $145.8 million (Q4 2025), and $63.5 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -45.51 Mn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -431.90 Mn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -428.90 Mn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 172.62 Mn
10 Arvinas 529.92 Mn -84.98 Mn - 13.70 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 13.70 Mn
Mar 31, 2026 13.70 Mn
Dec 31, 2025 145.80 Mn
Dec 31, 2025 145.80 Mn
Sep 30, 2025 63.50 Mn
Sep 30, 2025 63.50 Mn
Jun 30, 2025 128.80 Mn
Jun 30, 2025 128.80 Mn
Mar 31, 2025 69.50 Mn
Mar 31, 2025 69.50 Mn
Dec 31, 2024 98.90 Mn
Dec 31, 2024 98.90 Mn
Sep 30, 2024 50.50 Mn
Sep 30, 2024 50.50 Mn
Jun 30, 2024 13.10 Mn
Jun 30, 2024 13.10 Mn
Mar 31, 2024 -127.80 Mn
Mar 31, 2024 -127.80 Mn
Dec 31, 2023 -53.70 Mn
Dec 31, 2023 -53.70 Mn